Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB:RMCP) met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe. The company has already received signed pre-production commitment letters from some of these distributors for over 12 million syringes to be delivered next year and will continue to pursue full distribution agreements with additional sales volumes over the coming months. The Company's initial shipment date is still on schedule for March/April 2011.
"The whole Revolutions Medical team was very pleased with both receptions in Dusseldorf, Germany and in London, England. We always felt that we had a special product which is uniquely poised in the safety syringe market and now this has been confirmed with the overall excitement and volume commitments by distributors. We do expect to receive additional signed commitment letters soon as we ramp up production with our Chinese factory early next year and continue with our global marketing and distribution plans," states Ron Wheet, CEO, Revolutions Medical Corporation.
The Company also launched its new interactive website www.revolutionsmedical.com to take advantage of new media technology with blogs, Twitter, and visual uploads, to keep shareholders, investors, and customers more current on news and events. Soon customers will be able to order syringes online in a safe, secure environment, and by the 3rd quarter 2011 will also be able to send images to access our proprietary MRI software tools; RevColor, RevDisplay, and Rev3d.